Mucosal immunisation and immunoprophylaxis as potential strategies for prevention of SARS.
Foxwell
A R
AR
Gadi Research Centre for Medical and Health Sciences, University of Canberra, Canberra, ACT 2601, Australia. ruth.foxwell@canberra.edu.au
Cripps
A W
AW
D000818:Animals; D002522:Chlorocebus aethiops; D018928:Immunity, Mucosal; D008562:Membrane Glycoproteins / Q000276:immunology; D022241:Parainfluenza Vaccines; D029101:Parainfluenza Virus 3, Bovine / Q000276:immunology*; D045473:Severe acute respiratory syndrome-related coronavirus / Q000276:immunology*; D045169:Severe Acute Respiratory Syndrome / Q000276:immunology / Q000517:prevention & control*; D064370:Spike Glycoprotein, Coronavirus; D014611:Vaccination; D014613:Vaccines, Attenuated; D014759:Viral Envelope Proteins / Q000276:immunology; D014765:Viral Vaccines
D008562:Membrane Glycoproteins; D022241:Parainfluenza Vaccines; D064370:Spike Glycoprotein, Coronavirus; D014613:Vaccines, Attenuated; D014759:Viral Envelope Proteins; D014765:Viral Vaccines